Psychemedics Corp
NASDAQ:PMD

Watchlist Manager
Psychemedics Corp Logo
Psychemedics Corp
NASDAQ:PMD
Watchlist
Price: 2.67 USD -1.84% Market Closed
Market Cap: 15.7m USD
Section:
 

Relative Value

The Relative Value of one PMD stock under the Base Case scenario is 3.71 USD. Compared to the current market price of 2.67 USD, Psychemedics Corp is Undervalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PMD Relative Value
Base Case
3.71 USD
Undervaluation 28%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
69
vs Industry
75
Median 3Y
0.8
Median 5Y
1.1
Industry
2.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-5.3
Median 5Y
-5.8
Industry
22.4
More Details
27.6
P/OCF
P/OCF
Price to OCF
27.6
vs History
19
vs Industry
17
Median 3Y
8.6
Median 5Y
8.8
Industry
14.4
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
38
Median 3Y
-12.1
Median 5Y
-11.1
Industry
21.7
More Details
2.9
P/B
P/B
Price to Book Value
2.9
vs History
22
vs Industry
38
Median 3Y
2.9
Median 5Y
2.9
Industry
2.2
More Details
0.7
EV/S
EV/S
Enterprise Value to Sales
0.7
vs History
66
vs Industry
78
Median 3Y
0.7
Median 5Y
1
Industry
2.5
More Details
1.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.9
vs History
66
vs Industry
75
Median 3Y
1.9
Median 5Y
2.7
Industry
5.1
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
32
Median 3Y
-8.9
Median 5Y
-7.6
Industry
12
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-5.2
Industry
16.9
More Details
26
EV/OCF
EV/OCF
Enterprise Value to OCF
26
vs History
19
vs Industry
20
Median 3Y
7.8
Median 5Y
8
Industry
14.5
More Details
30.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
30.7
vs History
19
vs Industry
20
Median 3Y
8.4
Median 5Y
8.4
Industry
18.6
More Details
2
EV/IC
EV/IC
Enterprise Value to IC
2
vs History
4
vs Industry
46
Median 3Y
1.8
Median 5Y
1.8
Industry
1.8
More Details

Multiples Across Competitors

PMD Competitors Multiples
Psychemedics Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Psychemedics Corp
NASDAQ:PMD
15.7m USD 0.8 -5.3 -8.9 -5.1
US
CVS Health Corp
NYSE:CVS
98.7B USD 0.3 210.5 13.9 13.9
US
Cigna Group
XMUN:CGN
62.3B EUR 0.3 11.9 7.7 9.7
US
Cigna Corp
NYSE:CI
72.5B USD 0.3 11.8 7.6 9.7
DE
Fresenius SE & Co KGaA
XETRA:FRE
27.2B EUR 1.2 23.8 10.4 15.8
DE
Fresenius Medical Care AG
XMUN:FME
23.6B EUR 1.2 32.9 10.3 22.1
US
Laboratory Corporation of America Holdings
NYSE:LH
20.9B USD 1.5 24.5 13.4 18.7
US
Quest Diagnostics Inc
NYSE:DGX
19.5B USD 1.8 20.3 11.3 15.2
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.7B EUR 0.6 16.3 6.4 13.6
US
Guardant Health Inc
NASDAQ:GH
12.5B USD 13.8 -31.3 -33 -30
US
DaVita Inc
NYSE:DVA
8.2B USD 0.6 10.6 6.7 9.1
P/E Multiple
Earnings Growth PEG
US
Psychemedics Corp
NASDAQ:PMD
Average P/E: 40.3
Negative Multiple: -5.3 		N/A N/A
US
CVS Health Corp
NYSE:CVS
210.5
31%
6.8
US
C
Cigna Group
XMUN:CGN
11.9
39%
0.3
US
Cigna Corp
NYSE:CI
11.8
39%
0.3
DE
Fresenius SE & Co KGaA
XETRA:FRE
23.8
71%
0.3
DE
Fresenius Medical Care AG
XMUN:FME
32.9
37%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
24.5
30%
0.8
US
Quest Diagnostics Inc
NYSE:DGX
20.3
14%
1.4
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
16.3
37%
0.4
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -31.3 N/A N/A
US
DaVita Inc
NYSE:DVA
10.6
4%
2.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Psychemedics Corp
NASDAQ:PMD
Average EV/EBITDA: 9.7
Negative Multiple: -8.9 		N/A N/A
US
CVS Health Corp
NYSE:CVS
13.9
25%
0.6
US
C
Cigna Group
XMUN:CGN
7.7
4%
1.9
US
Cigna Corp
NYSE:CI
7.6
4%
1.9
DE
Fresenius SE & Co KGaA
XETRA:FRE
10.4
14%
0.7
DE
Fresenius Medical Care AG
XMUN:FME
10.3
10%
1
US
Laboratory Corporation of America Holdings
NYSE:LH
13.4
16%
0.8
US
Quest Diagnostics Inc
NYSE:DGX
11.3
8%
1.4
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
6.4
10%
0.6
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -33 N/A N/A
US
DaVita Inc
NYSE:DVA
6.7
4%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Psychemedics Corp
NASDAQ:PMD
Average EV/EBIT: 14.2
Negative Multiple: -5.1 		N/A N/A
US
CVS Health Corp
NYSE:CVS
13.9
18%
0.8
US
C
Cigna Group
XMUN:CGN
9.7
4%
2.4
US
Cigna Corp
NYSE:CI
9.7
4%
2.4
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.8
20%
0.8
DE
Fresenius Medical Care AG
XMUN:FME
22.1
25%
0.9
US
Laboratory Corporation of America Holdings
NYSE:LH
18.7
27%
0.7
US
Quest Diagnostics Inc
NYSE:DGX
15.2
11%
1.4
DE
F
Fresenius Medical Care AG & Co KGaA
XETRA:FME
13.6
25%
0.5
US
Guardant Health Inc
NASDAQ:GH
Negative Multiple: -30 N/A N/A
US
DaVita Inc
NYSE:DVA
9.1
4%
2.3

See Also

Summary
PMD intrinsic value, competitors valuation, and company profile.
DCF Valuation
PMD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PMD stock valuation using valuation multiples.
Wall Street Estimates
PMD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PMD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 304,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.